histidine has been researched along with Atrophy, Muscular, Peroneal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, P; Lv, X; Wang, G; Xu, L; Yan, C; Zhang, D | 1 |
| Attarian, S; Behin, A; Beze-Beyrie, P; Bonello-Palot, N; Boyer, A; Campana-Salort, E; Delague, V; Esselin, F; Latour, P; Levy, N; Lia, AS; Magdelaine, C; Morel, V; Querin, G; Stojkovic, T; Walther-Louvier, U | 1 |
| Beharry, A; Duennwald, M; Heinemann, IU; Hsu, SY; Kenana, R; Qiu, Y; Siu, VM; Wilhelm, SDP | 1 |
| Heinemann, IU; Kenana, R; O'Donoghue, P; Qiu, Y; Wilhelm, SDP | 1 |
| Calderon, JLC; King, LE; King, SJ; Ledray, AP; Love, R; Nandini, S; Pasos, J; Sabblah, TT | 1 |
| Bereznai, B; Gál, A; Inczédy-Farkas, G; Karcagi, V; Mechler, F; Molnár, MJ; Pál, Z; Reményi, V | 1 |
| Antonellis, A; Biesecker, L; Giblin, W; Hou, YM; Kennerson, M; Lee, YC; Lupski, JR; McLaughlin, HM; Nicholson, G; Sakaguchi, R; Talbot, K; Vance, JM; Wilson, TE; Züchner, S | 1 |
| Ammar, N; Amouri, R; Barisić, N; Ceuterick, C; De Jonghe, P; Hentati, F; Martin, JJ; Merlini, L; Nelis, E; Timmerman, V | 1 |
| Battaloglu, E; Ciftci, F; Deymeer, F; Eraksoy, M; Halefoglu, AM; Oge, AE; Parman, Y; Poyraz, M; Saruhan-Direskeneli, G | 1 |
| Brannagan, TH; Chin, RL; Sander, HW; Seltzer, WK; Souayah, N | 1 |
| Hashimoto, T; Hayasaka, K; Ikegami, T; Kashiwada, E; Murai, Y; Ohashi, H; Ohnishi, A; Sudo, K; Yamamori, S; Yamamoto, T | 1 |
| MacMillan, J; Sorour, E; Upadhyaya, M | 1 |
| Fukushima, Y; Ikeda, M; Ohnishi, A; Sudo, K; Yamamori, S; Yamamoto, T | 1 |
3 review(s) available for histidine and Atrophy, Muscular, Peroneal
| Article | Year |
|---|---|
A novel mutation in HINT1 gene causes autosomal recessive axonal neuropathy with neuromyotonia, effective treatment with carbamazepine and review of the literature.
Topics: Adolescent; Carbamazepine; Charcot-Marie-Tooth Disease; Histidine; Humans; Isaacs Syndrome; Muscle Cramp; Mutation; Nerve Tissue Proteins; Nucleotides; Peripheral Nervous System Diseases | 2022 |
HINT1 neuropathy: Expanding the genotype and phenotype spectrum.
Topics: Charcot-Marie-Tooth Disease; Genotype; Histidine; Humans; Isaacs Syndrome; Mutation; Nerve Tissue Proteins; Nucleotides; Peripheral Nervous System Diseases; Phenotype | 2022 |
Towards a Cure for HARS Disease.
Topics: Aminoacylation; Charcot-Marie-Tooth Disease; Histidine; Histidine-tRNA Ligase; Humans; Mutation | 2023 |
10 other study(ies) available for histidine and Atrophy, Muscular, Peroneal
| Article | Year |
|---|---|
Histidine supplementation can escalate or rescue HARS deficiency in a Charcot-Marie-Tooth disease model.
Topics: Amino Acyl-tRNA Synthetases; Charcot-Marie-Tooth Disease; Dietary Supplements; Histidine; Humans; Mutation; RNA, Transfer; Saccharomyces cerevisiae | 2023 |
A novel mouse model carrying a human cytoplasmic dynein mutation shows motor behavior deficits consistent with Charcot-Marie-Tooth type 2O disease.
Topics: Amino Acid Substitution; Animals; Animals, Genetically Modified; Arginine; Charcot-Marie-Tooth Disease; Cytoplasmic Dyneins; Disease Models, Animal; Gene Knock-In Techniques; Histidine; Humans; Longitudinal Studies; Male; Mice; Mutant Proteins; Mutation, Missense | 2018 |
The modifying effect a PMP22 deletion in a family with Charcot-Marie-Tooth type 1 neuropathy due to an EGR2 mutation.
Topics: Adult; Age of Onset; Amino Acid Substitution; Arginine; Charcot-Marie-Tooth Disease; Early Growth Response Protein 2; Gene Deletion; Histidine; Humans; Male; Median Nerve; Middle Aged; Myelin Proteins; Neural Conduction; Peroneal Nerve; Sural Nerve; Ulnar Nerve | 2014 |
A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).
Topics: Alanine-tRNA Ligase; Aminoacylation; Arginine; Australia; Axons; Case-Control Studies; Charcot-Marie-Tooth Disease; CpG Islands; Female; France; Genes, Dominant; Genetic Linkage; Haplotypes; Histidine; Humans; Male; Molecular Sequence Data; Mutation; Pedigree; Transfer RNA Aminoacylation; Yeasts | 2012 |
Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease.
Topics: Alleles; Arginine; Charcot-Marie-Tooth Disease; Cysteine; Demyelinating Diseases; DNA Mutational Analysis; Electrophysiology; Family Health; Female; Genetic Predisposition to Disease; Glycine; Histidine; Humans; Male; Microscopy, Electron; Mutation; Nerve Tissue Proteins; Neural Conduction; Pedigree; Peripheral Nerves; Sequence Analysis, DNA; Tryptophan | 2003 |
X-linked Charcot-Marie-Tooth disease and multiple sclerosis.
Topics: Adult; Central Nervous System; Charcot-Marie-Tooth Disease; Chromosomes, Human, X; Connexins; Gap Junction beta-1 Protein; Histidine; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Mutation; Tyrosine | 2007 |
Rare myelin protein zero sequence variant in late onset CMT1B.
Topics: Aged; Charcot-Marie-Tooth Disease; Family Health; Female; Histidine; Humans; Middle Aged; Mutation; Myelin P0 Protein; Neural Conduction; Proline | 2007 |
[A family of hereditary motor and sensory neuropathy type I with a mutation (Arg98-->His) in myelin Po--report on a second Japanese family].
Topics: Arginine; Charcot-Marie-Tooth Disease; Family Health; Female; Histidine; Humans; Japan; Male; Middle Aged; Myelin P0 Protein; Pedigree; Point Mutation | 1996 |
Novel mutation of the myelin P0 gene in a CMT1B family.
Topics: Arginine; Charcot-Marie-Tooth Disease; Female; Genes, Dominant; Histidine; Humans; Male; Mutation; Myelin Proteins; Pedigree | 1997 |
Myelinated fibers in Charcot-Marie-Tooth disease type 1B with Arg98His mutation of Po protein.
Topics: Adult; Arginine; Charcot-Marie-Tooth Disease; Female; Histidine; Humans; Japan; Male; Middle Aged; Myelin P0 Protein; Nerve Fibers, Myelinated; Neural Conduction; Pedigree; Point Mutation | 1999 |